VT
Ventyx Bio
VTYX·NASDAQEncinitas CAFounded 2019120 employees
Small CapbiotechPublicImmunology
Platform: Oral Immunol
Market Cap
$1.2B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (VTYX)
Loading VTYX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rilucapivasertib | VTY-8598 | Phase 2/3 | 1 | JAK2 | NASH | ||
| Rimatinib | VTY-9379 | Phase 1 | 2 | CD20 | PompeUrothelial Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)